The Effect of Bifid Triple Viable on Immune Function of Patients with Ulcerative Colitis

Yokoyama, K., Kobayashi, K., Mukae, M., Sada, M., & Koizumi, W. (2013). Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis. Gastroenterology Research and Practice, 2013(), 118-123-017. https://doi.org/10.1155/2013/192794
Furusho, J. K. Y., Gutiérrez, I. A., Carballeda, J. F., & Camarillo, G. F. (2015). Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis. Mediators of Inflammation, 2015(), 518-525-352. https://doi.org/10.1155/2015/659018
Tam, T. N., Ng, W. W., Lu, R. H., & Chang, F. Y. (2000). The Correlation of Clinical Activities to Serum Interleukin-6 Concentration in Patients with Ulcerative Colitis. 中華民國消化系醫學雜誌, 17(2), 118-124. https://doi.org/10.6557/GJTb.200006_17(2).0002
Hsi, K. Y., Hsu, T. C., & Chen, M. J. (2019). Surgical Management of Fulminant Colitis in Patients with Ulcerative Colitis. 中華民國大腸直腸外科醫學會雜誌, 30(4), 148-154. https://doi.org/10.6312/SCRSTW.201912_30(4).10808
Refaat, M. M., Ahmed, T. M., Eldin, S. S., Kamal, A. T., & Elnour, N. A. (2012). Atopic Manifestations in Patients with Inflammatory Bowel Disease. Journal of pioneering medical sciences, 2(3), 109-114. https://www.airitilibrary.com/Article/Detail?DocID=P20160812001-201209-201608150013-201608150013-109-114